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ABSTRAK 
Pembedahan kolisistektomi adalah merupakan rawatan yang standard bagi 
penyakit batu kamng hempedu, lebih-Iebih lagi dengan adanya teknik terbaru 
pembedahan iaitu pembedahan laparoskopi yang telah dikenalpasti mempunyai 
beberapa kelebihan. Walaubagaimanapun, terdapat 6 hingga 39 peratus pesakit yang 
telah menjalani pembedahan tersebut masih mempunyai simptom-simptom penyakit 
batu karang hempedu yang dialaminya sebelum pembedahan atau timbulnya 
simptom-simptom bam yang berkaitan. Kajian yang sarna terdahulu hanya mengkaji 
simptom-simptom yang kekal atau timbul setahun selepas pembedahan. Tambahan 
pula, tiada data tempatan mengenai sindrom pascakolisistektomi ini. 
Tujuan kajian ini dilakukan adalah untuk mengetahui insiden sindrom 
pascakolisistektomi 2 tabun atau lebih selepas pembedahan laparoskopi kolisistektomi 
dilakukan di Hospital Universiti Sains Malaysia di antara Mac 1995 hingga Disember 
1998. Pada masa yang sarna juga, penyebab sindrom pascakolisistektomi yang 
signifikan dapat ditentukan. 
Kajian ini adalab kajian berbentuk diskriptifretrospektifyang melibatkan 127 
pesakit hospital ini yang telah menjalani pembedahan elektif laparoskopi 
kolisistektomi yang tidak berkompIikasi. Maklumat-maklumat berkenaan dengan 
demografi, indikasi pembedahan, dan simptom-simptom pascakolisistektomi beserta 
penyiasatannya dan rawatannya di dalarn rekod pesakit dianalisa. 
11 (8.7%) pesakit didapati mempunyai sindrom pascakolisistektomi. 5 pesakit 
mempunyai simptom penyakit batu karang hempedu yang tipikal manakala 6 pesakit 
Jagi mempunyai simptom yang tidak tipikal. Mean tempoh masa simptom yang 
tersebut dihidapi oleh pesakit adalah 36.2 bulan. 72.7% pesakit tersebut mempunyai 
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sejarah penyakit dalaman manakala 18.2% pemah menjalani prosedur pembedahan. 
54.5% mengalami sindrom klinikaI kolik biliari, 27.3% sindrom klinikal kolisistitis 
yang kronik dan 18.2% sindrom klinikal pankreatitis. Analisis univariasi hanya 
mendapati pesakit yang mempunyai sindrom klinikal kolisistitis yang kronik sahaja 
yang ada kaitan dengan sindrom pascakolisistektomi (p<O.05). Manakala sindrom 
klinikal kolik biliari dan pesakit yang mepunyai sejarah penyakit atau pemah 
menjalani pembedahan tidak signifikan dalam perkaitannya. Seorang pesakit 
rnengalami penyakit barah usus besar sigmoid. Tiada pesakit yang mengalami 
sindrom tersebut berpunca penyakit hepatobiliari dan didapati penyiasatan rapi tidak 
dilakukan untuk memastikan sindrom pascakolisistektomi berpunca dari penyakit 
yang tersebut. 
Dirumuskan bahawa kajian ini telah memberi keputusan yang lebih kurang 
sarna dengan kajian terdahulu yang seumpamanya waJaupun selepas 2 tabun atau 
lebih daripada tarikh pembedahan. 
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ABSTRACT 
Cholecystectomy is considered the gold standard treatment for symptomatic 
gallstones disease especially with the advent of laparoscopic approach, which is 
known to have well documented advantages. Nevertheless, 6% to 39% of the patients 
continue to have either persistent symptoms or emergence of new symptoms 
suggestive of gallstone disease after the laparoscopic cholecystectomy. All the 
previous studies were looking at the postcholecystectomy symptoms or syndrome one 
year after the surgery. Furthermore, there is no local data regarding the 
postcholecystectomy syndrome as yet. 
The aim of this study is to know the incidence of the postcholecystectomy 
syndrome after 2 years and beyond the laparoscopic cholecystectomy done in the 
Hospital Universiti Sains Malaysia from March 1995 until December 1998. At the 
same time, any significant pathology that gives rise to the syndrome is reviewed. 
This is retrospective descriptive study of 127 patients who underwent 
uncomplicated elective Iaparoscopic cholecystectomy in this hospital. Patients' 
records were reviewed for demographic data, indications for surgery, and symptoms 
attributed to postcholecystectomy syndrome, their investigations and management. 
11 (8.7%) patients were noted to have postcholecystectomy syndrome. 5 
(45.5%) patients had typical symptoms of gallstone disease and 6 (54.5%) had 
atypical symptoms. Mean time interval the symptoms manifested for the first time 
was 36.2 months (24 to 55 months). 8 (72.7%) of the patients had medical illness and 
2 (18.2%) had history of past surgical procedures. Majority of them (n = 6, 54.5%) 
had clinical syndrome of biliary colic, 27.3% had chronic cholecystitis and 18.2% had 
pancreatitis. Univariate analysis revealed significant association with 
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postcholecystectomy syndrome only in patients with chronic cholecystitis (p<O.05) 
and not in biliary colic group (p=O.07), patients with history of medical illness 
(p=O.098) or surgical operations (p=O.181). One patient was noted to have sigmoid 
colon cancer 3 years after cholecystectomy. No patient with postcholecystectomy 
syndrome directly related to hepatobiliary pathology since it was not fully 
investigated. 
In conclusion, the incidence of postcholecystectomy syndrome in this 
retrospective study of local population was comparable with other previous studies 
even after 2 years and beyond of the surgery. 
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INTRODUCTION 
1.0: INTRODUCTION 
Cholecystectomy is still the gold standard for the treatment of symptomatic 
gallstones. Since the introduction of laparoscopic cholecystectomy by Mouret in 1987, it 
has rapidly gained popularity and is now considered the gold standard treatment for 
symptomatic gallstone disease (1,2). Its advantages over open cholecystectomy include 
reduced postoperative hospitalisation, reduced pain and morbidity, better cosmesis, early 
return to work and considerable financial savings (3,4,5,6). Gallstones are associated 
with a wide variety of symptoms. These include abdominal pain, pain related to fatty 
foods, nausea and vomiting as well as dyspepsia, abdominal bloating and increased 
flatulence. While cholecystectomy is the best treatment for symptomatic gallstones, 
recent studies show that up to 34 percent of patients still have symptoms after 
laparoscopic cholecystectomy(7). These symptoms either because of lack of 
improvement or relapse of symptoms initially attributed to the presence of gallstones or 
because of the emergence of new gastrointestinal complaints presumably related to the 
operation. The term postcholecystectomy syndrome(8) has been used to describe this 
condition which range from mild ill defined digestive symptoms to severe attacks of 
abdominal pain and jaundice. We therefore reviewed our local patients who continue to 
have significant postcholecystectomy syndrome after two years and beyond the 
laparoscopic cholecystectomy, which causing them to seek treatment since the advent of 
laparoscopic cholecystectomy practices in Hospital Universiti Sains Malaysia. 
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LITERATURE 
REVIEW 
2.0: LITERATURE REVIEW 
2.1: ANATOMY OF THE BILIARY SYSTEM 
2.1.1: ANATOMY OF THE EXTRAHEPATIC BILIARY TREE 
The biliary tree consists of fine intrahepatic biliary radicles, the right and left 
hepatic ducts, the common hepatic duct and the common bile duct. The left hepatic duct 
is formed within the umbilical fissure from the union of the three segmental ducts 
draining the left liver (segments II, III, and IV). The right hepatic duct drains segments 
V, VI, VII, and VIII. The biliary drainage of the caudate lobe (segment I) is variable (9). 
In 80% of the individuals, the caudate lobe drains into both the right and left hepatic 
ducts; in 15% of patients, the caudate lobe drains only into the left hepatic duct; and in 
the remaining 5% of cases, the lobe is drained exclusively by the right hepatic duct. 
The right and left hepatic ducts converge to form the common hepatic duct occurs 
in an extrahepatic location anterior to the portal venous bifurcation. The extrahepatic 
portion of the right duct is short whereas the left hepatic duct has an extrahepatic length 
of2 cm or more (9). 
The common hepatic duct descends in the hepatoduodenalligament and is joined 
at a variable position by the cystic duct to form the common bile duct, which ends at the 
papilla of Vater, usually in the second part of the duodenum. The common bile duct is 
approximately 8 cm in length and up to 10 mm in diameter (10). The upper third, or 
supraduodenal portion, of the common bile duct courses downward in the free edge of 
the lesser omentum, anterior to the portal vein and to the right of the hepatic artery. The 
middle third, or retroduodenal portion, of the common bile duct passes behind the first 
portion of the duodenum, lateml to the portal vein and anterior to the inferior vena cava. 
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The lower third, or intrapancreatic portion, of the common bile duct traverses the 
posterior aspect of the pancreas in a tunnel or groove to enter the second portion of the 
duodenum, where it is accompanied by the pancreatic duct of Wirsung. The intramural, 
or intraduodenal, portion of the common bile ducts passes obliquely through the 
duodenal wall to enter the duodenal lumen at the papilla of vater. 
The biliary ducts from intrahepatic biliary ductules till ampulla of vater may 
become pathologically dilated, usually congenitally, either the whole length or certain 
portion of the duct. This dilatation when present is called choledochal cyst. There is one 
reported case of postcholecystectomy symptom found to have solitary stone in the 
choledochal cyst (11). 
The gallbladder is a pear shaped; distensible reservoir lies in a bed on the 
undersurface of the liver between the right and left lobes. The gallbladder has a capacity 
of 30 to 50 ml. It is a muscular structure with a fundus, body and neck. The fundus is the 
rounded portion of the gallbladder that usually extends beyond the edge of the liver. 
Hartmann's pouch is a dilatation of the gallbladder outlet adjacent to the origin of the 
cystic duct in which gallstones frequently become impacted. It may obscure the junction 
of the cystic duct with the common hepatic duct. The gallbladder may occasionally be 
partially or completely embedded within the liver parenchyma (intrahepatic gallbladder) 
or abnormally positioned beneath the left lobe of the liver. The gallbladder may also be 
suspended from the cystic fossa by a complete mesenteric attachment that may 
predispose to torsion of the gallbladder. 
The cystic duct arises from the neck of the gallbladder and passes downward in 
the hepatoduodenal ligament to join the common hepatic duct at an acute angle. The 
length of the cystic duct is variable, ranging from 0.5 to 4 cm, depending upon the 
location of its union with the common hepatic duct. 
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2.1.2: ANOMALIES OF THE EXTRAHEPATIC BILIARY TREE 
Knowledge of the variable anatomy of the extrahepatic biliary tree is important 
for the general surgeon, because the failure to recognize anatomic variations may result 
in a significant ductal injury. 
There are five ductal anomalies of significance to the surgeon during 
perfonnance of a cholecystectomy (Figure 1) (12). These anomalies should be easily 
recognized at the time of operation by careful and meticulous dissections. One of the 
most common ductal variations is the presence of a long cystic duct with a low union 
with the common hepatic duct. In this case, the cystic duct is usually closely adherent to 
the hepatic duct for a variable length. Efforts to display the entire length of the cystic 
duct and its union with the common hepatic duct may result in a ductal injwy and should 
be avoided (12). 
Accessory hepatic ducts, usually from the right lobe of the liver, may join the 
common hepatic duct or cystic duct. These accessory ducts often course through the 
Callot's triangle and may be injured during dissection in this area. Segmental hepatic 
ducts may also directly enter the common hepatic duct, cystic duct, and, occasionally, the 
gallbladder. Small cholecystohepatic ducts from the liver may enter the gallbladder 
directly. If it is discovered during dissection of the gallbladder from the liver bed, it 
should be ligated to avoid a postoperative biliary leak. 
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Figure 1: Duct anomalies. 
A, Long cystic duct with low fusion with common hepatic duct. 
B, Abnormally high fusion of cystic duct with common hepatic duct (trifurcation). 
C, Accessory hepatic duct. 
D, Cystic duct entering right hepatic duct. 
E, Cholecystohepatic duct. 
(Adapted from Laparoscopic anatomy of the biliary tree; In Surgical Anatomy And 
Embryology, Surgical Clinic of North America. 
, . 
~. 
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2.2: PHYSIOLOGY 
Bile, which is formed in the liver, is made up of bile salts, bile pigments, and 
other substances namely cholesterol and alkaline phosphatase dissolved in an alkaline 
electrolyte solution. About 500 ml of the bile is secreted per day. Some of the 
components of the bile are reabsorbed in the intestine and then excreted again by the 
liver. 
The glucuronides of the bile pigments, biliverdin and bilirubin, which are also 
breakdown products of the haemoglobin, are responsible for the golden yellow colour of 
bile. 
Bile acids are sterols synthesized by the liver from cholesterol. The two primary 
bile acids are chenodeoxycholic and cholic acid; these are conjugated with glycine or 
taurine, derivative of cystine, to form sodium and potassium salts of bile acids, 
glycocholic and taurocholic acid, in the alkaline hepatic bile. The conjugation will 
increase their solubility in water. In the colon, bacteria convert cholic acid to 
deoxycholic acid and lithocholic acid, secondary bile acids. 
Bile salts have a number of important actions. The bile saIts can combine with 
lipids to fonn micelles, water-soluble complexes from which the lipids can be more 
easily absorbed. They are also detergents and reduction in surface tension allows fat to 
be emulsified in the intestine, thus facilitating its digestion and absorption. 
On reaching the distal ileum, 90 to 95% of the bile salts are reabsorbed back by 
mostly active transport process and then transported back to the liver and passed once 
again into the biliary system( 13). The remaining 5% enter the colon and are converted to 
the salts of deoxycholic acid and lithocholic acid. Lithocolate is relatiovely insoluble and 
is mostly excreted in the stools; only 1 % is absorbed. However deoxycholate is absorbed. 
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The absorbed bile salts are transported back to the liver via the portal vein and reexcreted 
in the bile. This is called enterohepatic circulation allows a relatively small bile saIt pool 
(2-4 g) to circulate some 6-8 times per day through the intestine( 13). The daily faecal 
loss equals that of hepatic synthesis (0.2-0.6 g/24 h) (10). When the bile is excluded from 
the intestine, up to 50% of ingested fat appears in the faeces (13). 
Bile flows into the gallbladder when the sphincter of Oddi is closed. The 
gallbladder has a capacity of 50 ml. In the gallbladder, the bile is concentrated by 
absorption of water. It contracts in response to cholecystokinin (CCK), which is released 
from the duodenal mucosa by the presence of food, notably fatty acids. Gallbladder 
contraction is accompanied by reciprocal relaxation of the sphincter of Oddi. The 
production and secretion of the bile is increased by the hormone secretin and by 
stimulation of the vagus nerves. 
2.3: PATHOGENESIS OF GALLSTONES 
Gallstones are formed from the constituents of bile. The great majority of stones 
result from failure to keep cholesterol in micellar form in the gallbladder, and pigment 
stones (composed of calcium bilirubinate) are mre in the western countries but common 
in the tropical countries. Most cholesterol stones become mixed with bile pigments as 
they increase in size; such "mixed" stones are much more common than pure cholesterol 
stones. 
Gallstones are common in Europe and North America and less common in Asia 
and Africa (14). Their incidence increases with age. In developed countries they occur in 
at least 20% of women over the age of 40; the incidence in males is about one-third of 
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that in females (15). The disease has increased markedly in frequency and 
cholecystectomy is the commonest major elective abdominal operation in many Western 
countries (16). 
Cholesterol Stones 
Cholesterol stones may occur in both sexes from the late teens onwards but are 
particularly common in middle aged, obese, multiparous females. Stone fonnation is 
encouraged if bile becomes supersaturated with cholesterol (i.e. lithogenic) either by 
excessive cholesterol excretion or by reduction in the amount of bile salt and lecithin 
available for micelle formation (14). Supersaturation is likely to occur during the 
concentration of bile while it is within gallbladder, and is favoured by stasis or decreased 
gallbladder contractility. The formation of cholesterol crystals is the key event, and this 
nucleation may be due to coalescence of cholesterol molecule around particles of mucus, 
bacteria, calcium bilirubinate or mucosal cells. Not all individual with supersaturated bile 
develop gallstones so that other factors must be implicated. Pure cholesterol stone are 
yellowish-green with a regular shape but rough swface. They are usually solitary. In 
contrast, mixed stones are darker and are usually multiple. 
Cholesterol stones are particularly common in some tribes of north American 
Indians, where more than 75% of women over 40 are affected (14). Such individual have 
a small bile salt pool. Conversely, the high incidence of stones in Chilean women reflects 
high levels of excretion (15). 
Obesity and high-calorie or high-cholesterol diets favour cholesterol stone 
formation by producingly high supersaturated gallbladder bile, Drastic weight reduction 
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and diets designed to lower serum cholesterol levels may also promote stone formation 
by mobilising cholesterol and increasing its excretion. 
Disease or resection of the tenninaI ileum and drugs such as cholestyramine may 
favour cholesterol nucleation by reducing bile salt pool. Hormonal influences are 
reflected in an increased of stone formation in women taking oral contraceptives or 
postmenopausal oestrogen replacement. Pregnancy may also have an effect by increasing 
stasis within the gallbladder. Similarly, after vagotomy the gallbladder become flaccid 
and increases in volume. Hypercholesterolaemia as such is not associated with stone 
formation. 
Pigment stones 
Pigment stones consist of calcium bilirubinate and are usually multiple, small and 
amorphous. Stones found in occidental patients are usually composed of black pigments, 
whereas brown pigments stones are common in orientals. Pigment stones account for 
25% of all gallstones in Western patients but for 60% of those in some oriental countries 
such as Japan (15). 
Chronic haennolysis favours pigment stone formation by increasing pigment 
excretion, and stone formation IS common in congenital spherocytosis, 
heamoglobinopatby and malaria. Cirrhosis and biliary stasis are also important 
associations. Some patients with brown pigment stones have increased concentrations of 
unconjugated bilirubin in the bile. In oriental patients this may be due to the action of 
beta-glucuronidase, which is produced by E. coli and which invades ductal systems 
infested with the parasites Clonorchis sinensis or Ascaris lumbricoides (15). 
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2.4: COMMON CLINICAL SYNDROMES ASSOCIATED WITH GALLSTONES 
The majority of individuals with gallstones is asymptomatic or has only vague 
symptoms of distension and flatulence. Half of such patients will develop some 
symptoms or complications due to gallstones within 10 years. Gallstones may give rise 
to symptoms in several ways. 
Biliary colic 
Biliary colic is due to transient obstruction of the gallbladder from an impacted 
stone. There is severe gripping pain, often developing in the evening, and maximal in the 
evening, and maximal in the epigastriwn and right hypochondrium with radiation to the 
back. Though continuous, the pain may wax and wane in intensity over several hours. 
Vomiting and retching occur. Resolution follows when the stone falls back into the 
common gallbladder lumen or passes onwards into the common bile duct. The patient 
recovers rapidly but repeated bouts of colic are common. 
Acute cholecystitis 
Acute cholecystitis results in a more prolonged and severe illness. It usually 
begins with an attack of biliary colic, though its onset may be more gradual. There is 
severe right hypochondrial pain radiating to the right subscapular region, and 
occasionally to the right shoulder (from diaphragmatic irritation), together with 
tachycardia, pyrexia, nausea, vomiting and leucocytosis. Abdominal tenderness and 
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rigidity may be generalized but are most marked over the gallbladder. Murphy's sign (a 
catching of the breath at the height of inspiration while the gallbladder is palpated) is 
usually present. A right hypochondrial mass may be felt. This is due to omentum 
"wrapped" around the inflamed gallbladder. 
In 85-90% of cases the attack settles within 4-5 days (15). In the remainder, 
tenderness may spread and pyrexia signals empyema formation. The gallbladder may 
become gangrenous and perforate, giving rise to biliary peritonitis. 
Jaundice can develop during the acute attack. Usually this is associated with 
stones in the common bile duct but compression of the bile ducts by the gallbladder may 
be responsible. 
Acute cholecystitis must be differentiated from perforated peptic ulcer, high 
retrocaecal appendicitis, acute pancreatitis, myocardial infarction and basal pneumonia. 
Acute cholecystitis can develop in the absence of gallstones (acalculous cholecystitis). 
This is rare. 
Chronic cholecystitis 
Chronic cholecystitis is the common form of symptomatic gallbladder disease. It 
IS almost invariably associated with gallstones. Recurrent flatulence, right upper 
quadrant pain and fatty food intolerance are common. The pain is worse after meals and 
is often associated with a feeling of distension and heartburn. 
The differential diagnosis includes duodenal ulcer, hiatus hernia, myocardial 
ischaemia, chronic pancreatitis and gastrointestinal neoplasia. 
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Mucocele 
A pirifonn swelling is palpable in the right hypochondrium. It is not tender and 
there is no pyrexia. 
2.5: CHOLECYSTECTOMY 
For over 100 years cholecystectomy has been the standard treatment for 
symptomatic cholelithiasis. Cholecystectomy, first performed in 1882 by Langenbeck in 
Berlin. It is one of the most common surgical procedures done in western industrialized 
societies, is widely acknowledged to be safe, simple opemtion which defmitely 
eradicates gallstones in the vast majority of patients (16). Cholecystectomy is considered 
the gold standard for the treatment of symptomatic gallstones, especially after the 
introduction of the laparoscopic technique (1,2). The overall morbidity ranges from 4 to 
6 percent and operative mortality, from 0.5 to 3.4 percent with increased mortality of 9 
percent for patients older than 65 years old and of 10 to 67 percent for patients with 
complications of gangrene and perforation (17). Alternative treatments for gallstones 
have been advocated recently including stone dissolution, lithotripsy and percutaneous 
stone removal. All of these approaches, however, leave the gallbladder in situ with the 
possibility of stone recurrence. The development of minimally invasive techniques in 
urology and gastroenterology has stimulated general surgeons to explore the therapeutic 
potential of laparoscopy in the management of gallbladder disease. 
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2.5.1: LAPAROSCOPIC CHOLECYSTECTOMY 
Mouret from France performed the first laparoscopic cholecystectomy in 
1987(13). Since its introduction, laparoscopic cholecystectomy has rapidly gained in 
popularity and is now considered the standard treatment for symptomatic gall stone 
disease (10,18). With experience and training, it is applicable to over 95 percent of 
patients (19). The procedure reproduces all the steps of standard laparotomy 
cholecystectomy. Its advantages over open surgery are well documented (4,5,6). These 
include reduced postoperative hospitalisation, reduced pain and morbidity, better 
cosmesis and considerable financial savings (4,5). The complication (morbidity rate 
between 2.00 to 6.87%) and death (mortality rate between 0.04 to 0.23%) rates are low 
for laparoscopic cholecystectomy (19). 
Patient selection 
The indications for laparoscopic cholecystectomy are the same as standard 
cholecystectomy( 19) and these include: 
Cholelithiasis & biliary colic or cholecystitis 
Symptomatic gallbladder polyp 
Gallstone pancreatitis 
Symptomatic biliary dyskinesia 
Calcified gallbladder wall 
Large gallstone >2 cm 
Nonfunctioning gallbladder 
Chronic typhoid carrier 
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Morbidly obese patients and prior upper abdominal surgery are no longer considered a 
contraindication (19). In fact, morbidly obese patients benefit greatly from a laparoscopic 
approach and are discharged the same or next day with little or no morbidity. 
Patient evaluation 
Patients with symptoms compatible with gallstone disease usually have diagnosis 
confirmed on ultrasonography, which provides information about the gallbladder wall 
thickness (chronic cholecystitis), pericholecystic fluid (acute cholecystitis), and the size 
of the common bile duct. Endoscopic retrograde cholangiopancreatography is indicated 
for patients with abnormal liver function tests suggesting common bile duct stones and 
for patients with gallstone pancreatitis who are not improving. 
Equipment 
The equipment required for laparoscopic cholecystectomy includes a high flow 
insuftlator (carbon dioxide), light source (xenon), high resolution camera (which will be 
attached to the endoscope), high resolution video monitor, irrigation device and 
electrocautery unit or ultrasonic scalpel. 
Technique 
Preoperative antibiotics can be used routinely or reserved for patients with 
medical risk factors and for patients with evidence of recent episodes of cholecystitis. In 
Hospital Universiti Sains Malaysia, antibiotic prophylaxis was given routinely though 
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there was no standardisation (19).The procedure is performed with the patient under 
general anaesthesia (20). The stomach is decompressed with a nasogastric tube to 
facilitate exposure but if an open technique (Hasson cannula) is used, it is unnecessary. 
With the patient in supine position, a 2 or 3 cm incision is made superior or 
inferior to the umbilicus. The Hasson c~ula is inserted. Insufflating CO2 into the 
peritoneal cavity creates pneumoperitoneum. A telescope with camera attached is 
inserted through the cannula and the abdominal and pelvic cavities are inspected. The 
other one 10 mm incision at the epigastric region and 2 incisions of 5 mm in size at the 
right subcostal margin are made under direct vision. Through the most lateral right 
subcostal cannula, a grasper retracts the fundus of the gallbladder over the liver toward 
the right hemidiaphragm. Through the other subcostal cannula, a grasper retracts the 
Hartmann's pouch laterally and anteriorly. The dissection is begun at the neck of the 
gallbladder and proceeds along the cystic duct. After the cystic duct and artery have been 
identified, a titanium clip is placed at the junction of the neck and cystic duct before it is 
transected. The gallbladder is dissected from its bed, and before the last attachments at 
the fundus are divided, the gallbladder bed is irrigated and is inspected for bleeding and 
bile leaks. The stumps of the cystic duct and artery are inspected for bleeding and bile 
leaks. Under direct vision the gallbladder is removed through the epigastric incision, 
most of the time together with the port. 
The subcostal cannulas are also removed under direct visualization. Small 
drainage tube is inserted under direct vision if there is considerable bile leakage or when 
it is considered necessary to the operating surgeon. Rectus sheath openings of the 
epigastric and umbilical incisions were closed with J needle vicryl suture. This is 
followed by skin closure with absorbable suture or adhesive tapes. The other two 5 mm 
incisions, only the skin is closed in a similar manner. 
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Complications 
There are six common surgical complications directly related to laparoscopic 
cholecystectomy namely: 
Bile duct injury (21) 
Bleeding (22) 
Bile spillage 
Stones in the peritoneal cavity (23) 
Wound infection 
Injury to another organ (24) or vessel (22) 
Other types of complications have been reported and are uncommon than these six. Duct 
injury is a severe injury, and its prevalence decreases with experience (21) and time (22). 
Bleeding can occur from avulsion of the cystic artery, from injury to the hepatic injury, 
or the liver bed. Major vascular injuries to the portal vein, vena cava, or aorta are rare 
(prevalence, 0.11 %) and require prompt exploratory laparotomy (22). Bile spillage may 
occur if the gallbladder is injured with the cautery unit or a grasper. Stones may escape 
from the gallbladder if the gallbladder is injured and opened. The stones should be 
retrieved because they may cause abscesses (23). Migration and development of 
gallstones in wounds and other places have been reported but are uncommon. Wound 
infection is a rare and minor problem. Because the incisions are small, infections are 
insignificant and typically resolve with dressings changes and antibiotics. Injury to the 
intestine (24) or another organ can occur with introduction of a cannula or insertion of an 
instrument without visualisation, when an electrocautery unit is on a high-power setting 
or inadvertently makes contact with an organ, or with a loop of bowel directly under the 
initial point of entry with the Hasson cannula. 
16 
Conversion to open cholecystectomy 
Conversion to standard open cholecystectomy is indicated if a safe dissection of 
the structure in the triangle of Calot cannot be performed, because of dense 
adhesions/fibrosis from previous surgery, the presence of Mirizzi syndrome and severe 
acute disease with gross inflammatory oedema. Conversion to open cholecystectomy 
may be necessary because of the onset of above complications which cannot be readily 
and safely dealt with by laparoscopic approach. 
2.6: POSTCHOLECYSTECTOMY SYNDROME 
Introduction 
Postcholecystectomy syndrome is defmed as relapse of symptoms initially 
attributed to the presence of gallstones or emergence of new gastrointestinal complaints 
presumably related to the operation (8). Luman et al preferred to use the term 
postcholecystectomy symptoms rather than postcholecystectomy syndrome because it 
gives more accurate description (25). It ranges from mild ill-defined digestive symptoms 
to severe attacks of abdominal pain and jaundice. Other symptoms include postprandial 
abdominal pain, heartburn, nausea, vomiting, dyspepsia, abdominal bloating and 
flatulence. 
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Epidemiology 
The reported incidence of persistent symptoms after cholecystectomy varies 
widely (Table 1). Studies that have assessed symptomatic outcome after open 
cholecystectomy have given varying results. Ros and Zambon prospectively evaluated 93 
patients two years after cholecystectomy (16). Only 53 patients were completely free of 
symptoms. Konsten et al followed up over 300 Dutch patients through postal 
questionnaires to their general practitioners at median interval of 10 years after 
cholecystectomy and reported symptoms in 18%(26). Gilliland and Traverso followed up 
over 600 patients for a mean of 45 months and found that 88% of patients had complete 
symptomatic relief after cholecystectomy (27). 
There were also several studies (Table 1) that have examined symptoms after 
laparoscopic cholecystectomy. In a three month follow up of 52 patients, Peters et af 
reported that 77% of patients considered their symptoms to have been cured by the 
procedure (28). In a comparative study of open and laparoscopic cholecystectomy, 
Velpen et al reported that 95% of patients considered that they had obtained overall 
symptomatic improvement and 93% of the patients were pleased with the end result 
regardless of the access used (3). Other studies by Mc Mahon et af (29), Wilson et af 
(16) and Peterli et al (30) support the findings of no difference in surgical approach by 
Velpen et al. 
Qureshi et al analysed patients perceptions of postoperative symptoms and global 
satisfaction (31). They noted that 25% of patients complained of more than two 
symptoms postoperatively but 84% considered the procedure to be a complete success. 
Study by Wilson and Macintyre, evaluated symptomatic outcome of 115 patients a year 
after laparoscopic cholecystectomy and compared the outcome with 200 patients who 
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had undergone the open procedure. Over 90% of patients in both groups considered the 
procedures to have been successful in achieving symptomatic relief (32). McMahon et al 
also reported that over 90% of patients were improved by the operation (29). None of 
these studies assessed patients' symptoms in a prospective manner; only patients' 
postoperative symptoms were evaluated and patients were either expected to list 
preoperative symptoms (31), or their case notes were reviewed. Luman et al 
prospectively analysed symptoms before and after laparoscopic cholecystectomy (25). 
Patients undergoing laparoscopic cholecystectomy were given standard questionnaires. 
The same questionnaires were administered again six months after the operation. They 
found that 13% had persistent pain and 3% developed diarrhea at follow up. They also 
concluded that abdominal bloating and psychiatric medications were predictive for 
persistence of pain after laparoscopic cholecystectomy. 
Recently published article by Peterli et al (33) in the World Journal of Surgery, 
December 2000 also analysed symptoms of postcholecystectomy syndrome after the 
surgery USIng standard questionnaire. They compared the prevalence of 
postcholecystectomy symptoms after open and laparoscopic cholecystectomy. There was 
no significant difference of the symptoms: 90% of patients after open and 94% after 
laparoscopic cholecystectomy had no or only minor symptoms. 
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Table 1: SEVERAL STUDIES ON POSTCHOLECYSTECTOMY SYNDRO:ME IN 
THE ENGLISH LITERATURE 
AUTHOR n DESIGN CHOLECYSTECTO~ INCIDENCE 
Luman etal 100 Prospective laparoscopic 13% 
1996(25) (questionnaire) 
Peterli _ et al 397 Prospective Open (n=163) 10% 
2000(33) (questionnaire) Laparoscopic (n=234) 6% 
(excluding mInor 
symptoms) 
Wilson etal 315 Prospective Open (n=200) 6.6% 
1993(32) (questionnaire) Laparoscopic (n= 115) 6.0% 
Mc Mahon et 299 Prospective Minilaparotomy (n= 148) Both 10 % 
aI1995(29) (questionnaire) Laparoscopic (n= 151 ) 
Qureshi et al 100 Prospective laparoscopic 39% 
1993(31) (questionnaire) 
Konsten et al 325 Prospective Open 18.5% 
1993(26) (questionnaire) 
Velpen etal 160 Prospective Open (n=80) Both 18 % 
1993(3) (questionnaire) Laparoscopic (n=80) 
Ros et al 124 Prospective Open 47% 
1987(16) (questionnaire) 
Gilliland et al 671 Retrospective Open 18% 
1990(27) 
Aetiology 
Removal of the gallbladder is associated with several physiological changes in 
the upper gastrointestinal tract which may account for the persistence of symptoms or the 
development of new symptoms after cholecystectomy (34). The cholecystosphincter of 
Oddi reflex (35), cholecysto-antral reflex (36) and cholecysto-oesophageal reflexes (37) 
are all disrupted, and a number of local upper gastrointestinal hormonal changes also 
occur after cholecystectomy (38,39). Thus, there is an increased incidence of gastritis, 
alkaline duodenogastric reflux and gastro-oesophageal reflux after cholecystectomy, all 
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of which may be the basis for postcholecystectomy syndrome (34). But, some 
authors( 40) did not consider organic diseases outwith the biliary tract, such as hiatus 
hernia, duodenal ulcer, pancreatitis, duodenal diverticulitis and irritable bowel syndrome, 
as causes of postcholecystectomy syndrome. 
Generally, causes of symptoms after cholecystectomy(29) may be divided into 
four categories:-
1. Common bile duct stones may have been overlooked. 
2. Other gastrointestinal conditions such as gastro-oesophageal reflux, peptic ulcer 
disease, and functional motility disorder may have coexisted and their symptoms 
erroneously attributed to gallstones. 
3. Loss of the reservoir function of the gallbladder has been shown to result in a 
number of adverse changes:-
a. Impairment of the antropyloric motor unit. 
b. Increased duodenogastric reflux. 
c. Increased gastro-oesophageal reflux. 
d. Reduced bile salt pool which may result in subclinical fat malabsorption 
and diarrhea. 
4. The abdominal wound may result in pain from nerve damage or the development 
of an incisional hernia. 
Clinical manifestations 
Clinical features of the syndrome consist of symptoms similar to those symptoms 
prior to cholecystectomy or symptoms referable to the biliary tract after the surgery. It 
ranges from mild ill-defined digestive symptoms to severe attacks of abdominal pain and 
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jaundice. Other symptoms include postprandial abdominal paIn, heartburn, nausea, 
vomiting, dyspepsia, abdominal bloating and flatulence. 
Bodvall(8) regards dyspepsia as the mildest form of the postcholecystectomy 
syndrome and this seems to be an integral part of gallstone disease, both before and after 
operation. Ros and Zambon(16) found that 22 of the 46 patients (almost 50%) had 
relapse of dyspepsia. Velpen et al(3) reported 18% of his study patients had diarrhea. 
Velpen et a/(3), Luman et a/(24) did not detect symptomatic relief from heartburn or de 
novo development of this symptom after laparoscopic cholecystectomy. The cure rate for 
nausea, vomiting, and early satiety was excellent as also reported by Velpen et ale 
Luman et a/ found that preoperative abdominal bloating, constipation, and the use 
of psychotropic drugs were significantly more common in the symptomatic group(25). 
Patients with persistent pain after laparoscopic cholecystectomy had a higher prevalence 
of normal or only minimally inflamed gall bladder histology than the asymptomatic 
group. These findings suggest that persistent abdominal pain laparoscopic 
cholecystectomy may have been due to underlying irritable bowel syndrome and were 
unrelated to gall stones. Indeed, McMahon et al showed that patients with the 
postcholecystectomy syndrome tended to be anxious and depressed (29) and it is well 
known that patients with irritable bowel syndrome and "functional dyspepsia" tend to be 
neurotic, anxious, and depressed(14). 
Possibility of scar-related pain could not be ruled out in those patients with 
normal investigation findings. In the era of open cholecystectomy high proportion of 
patients may attribute continued symptoms to the scar. Ros and Zambon(16) found that 
in 22% of their patients dull upper abdominal pain is attributed to the wound whereas 
Velpin et a/(3) reported 9% of scar-related pain. 
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Management 
Investigations are aiming towards finding the above causes of 
postcholecystectomy syndrome, which includes all modality of investigations of the 
hepatobiliary system namely liver function test (LFT), ultrasonography of the 
hepatobiliary system and endoscopic retrograde cholangiopancreatography (ERCP) (I I). 
The advent of ERCP has revolutionized the management of this syndrome. This 
investigation improved the assessment of patients as well as providing an opportunity for 
treatment at the same time especially if common duct stones are found. 
Goenka et al( 4 I) found that 117 (75%) out of 156 postcholecystectomy 
syndrome patients with successful ERCP had one or more abnormalities seen at ERCP. 
Bile duct stones (55 patients), benign strictures of bile duct (27 patients) were the 
common lesions detected. A significantly higher (p<O.OOI) positive diagnosis was 
possible at ERCP in patients presenting with jaundice (100%) as compared to those 
without jaundice (61.8%). 
Only if the hepatobiliary causes have been excluded then other modality such as 
upper gastrointestinal endoscopy is considered. 
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OBJECTIVES 
3.0: AIM:S 
1. To know the clinical epidemiology of the postcholecystectomy syndrome 
after two years and beyond of the laparoscopic cholecystectomy. 
2. To find out the incidence of postcholecystectomy syndrome in patients 
underwent laparoscopic cholecystectomy in Hospital Universiti Sains 
Malaysia. 
3. To study the approach and management of specific causes of 
postcholecystectomy syndrome. 
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